Inspire key facts
as of Oct 2026- Operator Developer of a health data platform intended to connect patients and researchers for medical discovery.
- Inspire is valued at approximately $136.3M as of Oct 2026 (last reported valuation).
- It has raised $68.2M; the latest was Later Stage VC ($10.0M) in Sep 2025.
- Notable investors include Azoic Ventures, Tenfore Holdings, Viscogliosi Bros..
- Status: Privately Held (backing).
Inspire's last reported valuation, Jun 2023. Nothing priced has surfaced since.
- ·Watch Inspire: the Monday email on marks, rounds and moves
Inspire funding rounds
No funding rounds for Inspire are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Inspire
3Inspire valuation
Inspire's last reported valuation was $136 million in Jun 2023. No priced round, secondary trade or fund mark has surfaced since.
Inspire investors
3 investors are on record for Inspire, including Azoic Ventures, Tenfore Holdings and Viscogliosi Bros..
About Inspire
Operator Developer of a health data platform intended to connect patients and researchers for medical discovery. The company's platform offers patient communities and data-sharing capabilities, enabling researchers and healthcare organizations to advance discoveries through real-world patient insights.
- Sector
- Healthcare
- HQ
- Arlington, VA, United States
- Founded
- 2005
- Employees
- 80
- Website
- inspireresearch.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.